A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration
Titel:
A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration
Auteur:
Poor, Stephen H. Weissgerber, Georges Adams, Christopher M. Bhatt, Harit Browning, David J. Chastain, James Ciulla, Thomas A. Ferriere, Michael Gedif, Kinfemichael Glazer, Louis C. Joondeph, Brian C. Normand, Guillaume Sheth, Veeral Watters, Christie Grosskreutz, Cynthia L.